ACS Medicinal Chemistry Letters · 2012 · 15 citations · 12 references
MedicineChemistryNuclear MedicineAnalytical ChemistryDiagnostic ImagingHybrid ImagingMagnetic Resonance Contrast MechanismsMagnetic Resonance ImagingMolecular Probe DevelopmentMultimodal ImagingRadiopharmaceutical DesignTargeted Imaging AgentsContrast Agent DesignContrast Agent SynthesisDual-modality ImagingMagnetic Resonance Imaging Contrast AgentsMolecular Imaging Probe DesignRadiopharmaceuticals For Hepatobiliary ImagingSensitivityTriple-modality Imaging
The work describes the synthesis and in vivo application of heterotrimetallic complexes of the type {Gd(H2O)[(M(H2O)(CO)3)2(1)]} {1 = DTPA-bis(histidyl-amide); M = Re (3a); (99m)Tc (3b)} for dual modality MR/SPECT imaging. Here, the DTPA-bis(histidylamide) conjugate functions as a trinucleating chelate incorporating Gd in the DTPA core with Re or (99m)Tc in the pair of histidylamide side arms. The two complexes are chemically equivalent as revealed by HPLC, and their "cocktail mixture" (3a + 3b) has demonstrated itself to be essentially a single bimodal imaging probe. The present system has thus overcome the sensitivity difference problem between MRI and SPECT and paved the way for practical applications.
12
Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity.
André Egli, Roger Alberto, Lesley Tannahill et al. · PubMed · 1999 · 143 citations
T. Koullourou, Louise S. Natrajan, Hiren Bhavsar et al. · Journal of the American Chemical Society · 2008 · 130 citations · Full text
Hans‐Jürgen Pietzsch, Amber Gupta, Martina Reisgys et al. · Bioconjugate Chemistry · 2000 · 99 citations